A 4 Year Combination Therapy of Growth Hormone (GH) and Gonadotropin-releasing Hormone (GnRH) Agonist in Children With a Short Predicted Height - No Study Results Posted

A 4 Year Combination Therapy of Growth Hormone (GH) and Gonadotropin-releasing Hormone (GnRH) Agonist in Children With a Short Predicted Height (ZomaTrip)

This study is ongoing, but not recruiting participants.

Study NCT00840944 Information provided by Belgian Study Group for Pediatric Endocrinology

First Received: February 10, 2009 Last Updated: June 2, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	April 2017
Estimated Primary Completion Date:	January 2017 (Final data collection date for primary outcome measure)